WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.4% of their position (700.00 shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $1.1K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/21/2023ACC: 0001213900-23-097689
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+700.00
Net shares
Net buyer
$1.1K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
700.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+500.00
Price / share
$1.63
Trade value
$815.00
% of position
0.3%
12/19/2023
169.22K→169.72K
Common Stock
Direct
Shares
+200.00
Price / share
$1.61
Trade value
$322.00
% of position
0.1%
12/20/2023
169.72K→169.92K
Total
Net shares
+700.00
Net value
$1.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2023 | P · Purchase | +500.00 | $1.63 | $815.00 | 0.3% | 169.22K | 169.72K |
| Common Stock Direct | 12/20/2023 | P · Purchase | +200.00 | $1.61 | $322.00 | 0.1% | 169.72K | 169.92K |
| Total | +700.00 | $1.14K | ||||||
Derivative Transactions0
No derivative transactions reported